InnarisBio Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
InnarisBio General Information
Description
Developer of a sol-gel intranasal technology designed to enable the painless and non-invasive delivery of pharmaceutical compounds directly to the brain. The company offers a unique sol-gel technology that allows for the conversion of liquid compounds into a gel upon contact with the nasal membrane, facilitating efficient drug delivery, thereby enhancing drug efficacy and improving patient experience and outcomes in the treatment of central nervous system disorders.
Contact Information
Website
www.innaris.bioCorporate Office
- Wallstraße 16
- 10179 Berlin
- Germany
Corporate Office
- Wallstraße 16
- 10179 Berlin
- Germany
InnarisBio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
InnarisBio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
InnarisBio FAQs
-
When was InnarisBio founded?
InnarisBio was founded in 2021.
-
Where is InnarisBio headquartered?
InnarisBio is headquartered in Berlin, Germany.
-
What industry is InnarisBio in?
InnarisBio’s primary industry is Drug Discovery.
-
Is InnarisBio a private or public company?
InnarisBio is a Private company.
-
What is InnarisBio’s current revenue?
The current revenue for InnarisBio is .
-
Who are InnarisBio’s investors?
AtaiBeckley and Uniquest have invested in InnarisBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
